PUBLIC COMPANY
saveAlexion Pharmaceuticals Inc
updated 3mo ago
Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.
community read0 votes
pipeline
9
marketed
5
phase 3
3
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(9)
pipeline depth9 products
3Phase 35Marketed1pre_registration
Marketed
asfotase alfa
Hypophosphatasia
Marketeddanicopan
Paroxysmal Nocturnal Hemoglobinuria
Marketedeculizumab
Paroxysmal Nocturnal Hemoglobinuria
Marketedravulizumab LA
Delayed Graft Function (DGF)
Complement C5
Marketedsebelipase alfa
Lysosomal Acid Lipase Deficiency
Phase 3cliramitug
Amyloid Cardiomyopathy
Phase 3efzimfotase alfa
Hypophosphatasia
Phase 3eneboparatide
Hypoparathyroidism
pre_registrationgefurulimab
Myasthenia Gravis
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSKThe FDA had several issues with ivonescimab, according to the letter. Elsewhere, Sellas shares rocketed on results for a leukemia vaccine and Biogen and Lilly struck up new R&D pacts.biopharma_dive · 2d ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that